Skip to main contentAI and Advanced
/
VIYASH · NSEBSE SENSEX74,413.3+0.10%BSE |
NIFTY 5023,268.4+0.22%NSE |
NIFTY BANK56,239.3-0.09%NSE |
NIFTY IT28,868.2-0.75%NSE |
NIFTY AUTO27,165.15+1.01%NSE |
NIFTY FMCG45,743.45+0.40%NSE |
NIFTY PHARMA26,353.3+0.79%NSE |
NIFTY 50022,629.3+0.43%NSE |
VI
NSE · Equity shares · Biotechnology & Drugs5.05 · 2.11%
Viyash Scientific Ltd VIYASH
NSE:INR 243.9
BSE:INR 243.7
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for VIYASH
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 238.85
Day rangeINR 236.85 — INR 248.65
52-week rangeINR 166.2 — INR 298
Volume63.69 L
Market cap11,944.16
P/E56.72
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)3,420.31
Net Income (INR Cr)177.29
Rev Growth (5 Year %)20.23
EPS Growth (5 Year %)0.83
P/E Ratio56.72
Book Value44.51
EPS4.53
Price/BV5.48Computed
Research path: Interpret Viyash Scientific Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
VIYASHViyash Scientific Ltd1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 4,628.39 | 1,601.95 | 1,540.38 |
| Accumulated Depreciation Total | -803.03 | -312.07 | -273.2 |
| Other Liabilities Total | 194.44 | 22.65 | 21.75 |
| Accrued Expenses | 3.2 | 7.33 | 0.99 |
| Long Term Debt | 302.09 | 273.88 | 142.72 |
| Common Stock Total | 87.37 | 50.06 | 49.89 |
| Other Equity Total | -401.97 | -515.17 | -493.68 |
| Other Current Assets Total | 16.44 | 7.43 | 18.92 |
| Prepaid Expenses | 15.49 | 6.97 | 6.7 |
| Total Assets | 4,628.39 | 1,601.95 | 1,540.38 |
| Current Portof LT Debt/Capital Leases | 27.91 | 20.18 | 70.01 |
| Additional Paid-In Capital | 1,004.42 | 920.45 | 900.32 |
| Cash | 255.76 | 62.66 | 64.81 |
| Total Equity | 2,911.06 | 704.47 | 656.56 |
| Long Term Investments | 0.02 | 0.01 | 0.89 |
| Retained Earnings(Accumulated Deficit) | 2,221.09 | 152.35 | 122.72 |
| Total Common Shares Outstanding | 43.69 | 25.03 | 24.94 |
| Property/Plant/Equipment Total-Gross | 2,009.66 | 611.5 | 584.43 |
| Tangible Book Valueper Share Common Eq | 44.51 | 16.07 | 14.43 |
| Goodwill Net | 868.72 | 248.79 | 234.93 |
| Total Liabilities | 1,717.33 | 897.47 | 883.82 |
| Total Debt | 489.97 | 481.24 | 487.69 |
| Short Term Investments | 1.85 | 0.54 | 3.98 |
| Cashand Short Term Investments | 257.61 | 63.2 | 68.79 |
| Total Receivables Net | 1,140.01 | 402.75 | 375.45 |
| Notes Payable/Short Term Debt | 121.52 | 160.87 | 245.87 |
| Deferred Income Tax | 32.77 | 3.74 | 6.87 |
| Accounts Receivable-Trade Net | 1,045.31 | 363.53 | 335.73 |
| Property/Plant/Equipment Total-Net | 1,206.63 | 299.43 | 311.23 |
| Minority Interest | 203.67 | 65.89 | 56.4 |
| Total Current Liabilities | 945.9 | 505 | 626.99 |
| Total Inventory | 825.01 | 393.38 | 353.01 |
| ESOP Debt Guarantee | 0.14 | 96.8 | 77.31 |
| Accounts Payable | 597.27 | 256.72 | 260.26 |
| Other Currentliabilities Total | 196.01 | 59.9 | 49.86 |
| Total Long Term Debt | 340.54 | 300.19 | 171.82 |
| Intangibles Net | 98.05 | 53.44 | 61.72 |
| Other Long Term Assets Total | 180.26 | 113.46 | 91.88 |
| Note Receivable-Long Term | 20.16 | 13.08 | 16.88 |
| Total Current Assets | 2,254.55 | 873.73 | 822.86 |
| Capital Lease Obligations | 38.44 | 26.31 | 29.1 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio105.4
Price to Sale Ratio3.49
Growth
Debt 5Yr CAGR %12.16
Margins
Operating Margin 12m10.43
Operating Margin 5y Avg5
Net Profit Margin 12m5.75
Net Profit Margin 5y1.64
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk43.25
Analyst consensus
ConsensusStrong Buy
Consensus score1.00
Analyst opinions3
Strong Sell count0
Sell count0
Hold count0
Buy count0
Strong Buy count3
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,944 | 4.66 L | 38.4 | — |
| Divi's Laboratories | INR 8,291.55 | 2.20 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,965 | 1.89 L | 72.73 | — |
| Cipla | INR 1,475 | 1.19 L | 27.57 | — |
| Zydus Lifesciences | INR 1,106.25 | 1.10 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 61.31%
- FII
- 4.50%
- MF
- 2.93%
- Other
- 31.26%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Relevant company news is unavailable.
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingAGM
- annual General MeetingPOM
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Viyash Scientific Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Viyash Scientific Limited, formerly SeQuent Scientific Limited, is an India-based integrated pharmaceutical company with a global footprint, operating in the domains of animal health (active pharmaceutical ingredients (APIs), and finished dosage formulations) and analytical services. The Company has eight manufacturing facilities, based in India, Turkey, Brazil, Spain and Germany. It is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It specializes in analytical and bioanalytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It offers analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer-developed methods or in-house method development.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- VIYASH
- BSE Code
- 512529
Questions
Stock FAQ
What is the symbol and ISIN of Viyash Scientific Ltd?
Viyash Scientific Ltd has the symbol VIYASH and ISIN - INE807F01027.
What is the current price of Viyash Scientific Ltd?
Viyash Scientific Ltd is currently trading at INR 243.90.
What are the year high and year low of Viyash Scientific Ltd?
Viyash Scientific Ltd has a year high of INR 298.00 and a year low of INR 166.20.
What is the market capitalization of Viyash Scientific Ltd?
Viyash Scientific Ltd has a market capitalization of INR 11,944.16 crore.
What is the P/E ratio of Viyash Scientific Ltd?
Viyash Scientific Ltd has a P/E ratio of 56.72.
What is the dividend yield of Viyash Scientific Ltd?
Viyash Scientific Ltd has a dividend yield of 0.00%.
How is the financial performance of Viyash Scientific Ltd based on revenue, net income, and EPS?
Viyash Scientific Ltd has revenue of INR 3,420.31 crore, net income of INR 177.29 crore, and EPS of INR 3.76.
What is the book value of Viyash Scientific Ltd?
Viyash Scientific Ltd has a book value of INR 44.51.
What is the debt-to-equity ratio of Viyash Scientific Ltd?
Viyash Scientific Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Viyash Scientific Ltd?
Viyash Scientific Ltd has a price-to-book ratio of 5.48 and a price-to-sales ratio of 3.49.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.